The West African country of Equatorial Guinea declared an outbreak of the Marburg virus disease in mid-February. There have been at least nine laboratory-confirmed cases, seven of which resulted ...

An illustration of the Marburg virus. ... Marburg virus belongs to the same family of viruses as Ebola and causes similar symptoms such as severe fatigue, headache and haemorrhaging.

Without treatment, Marburg can be fatal in up to 88% of people who fall ill with the disease. There are currently no approved vaccines or treatments specifically for this virus.

Marburg virus disease has killed 11 people and sickened 25 others in Rwanda, which declared an outbreak on Sept. 27. Similar to Ebola, the rare but very severe illness can be fatal in up to 88% of ...

Marburg virus causes severe viral hemorrhagic fever and 24% to 88% of people who contracted the disease in different outbreaks died. Latest U.S.

Marburg virus has only reached the US once before in 2008, when it was diagnosed in a woman who had returned from a two-week safari in Uganda. She was hospitalised but later made a full recovery ...

Marburg virus disease is spreading in Rwanda and has claimed 6 lives so far. Rwanda's Minister of Health, Sabin Nsanzimana, revealed that the victims and most of the infected are healthcare ...

The Marburg virus, while rare, is known to cause severe hemorrhagic fever and has a high mortality rate of up to 88 percent. It is typically spread to humans from fruit bats, ...

The WHO has confirmed an outbreak of the deadly Marburg Virus Disease in Ghana. Here's what to know about the Ebola relative from symptoms to spread.

Updated May 9, 2025 at 4:36 PM CDT. This story was updated on October 8 at 1:17 p.m. Rwanda is now a test lab for an experimental vaccine against the Marburg virus.

What is the Marburg virus? It's viral, haemorrhagic fever in the same family as Ebola. It's highly infectious and was initially detected in 1967 after outbreaks in Marburg and Frankfurt in Germany ...

Marburg is one scary disease. The fatality rate can be as high as 88%. There's no approved vaccine — yet. With one of the world's largest outbreaks, Rwanda is now testing a promising new vaccine.